These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11204357)

  • 1. In vitro susceptibilities of Paracoccidioides brasiliensis yeast form to antifungal drugs.
    Hahn RC; Hamdan JS
    Mycoses; 2000; 43(11-12):403-7. PubMed ID: 11204357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
    Rodero L; Canteros CE; Rivas C; Lee W; Davel G
    Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.
    Hahn RC; Fontes CJ; Batista RD; Hamdan JS
    J Clin Microbiol; 2002 Aug; 40(8):2828-31. PubMed ID: 12149337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of in vitro antibiotic activity of saperconazole and other azoles on Paracoccidioides brasiliensis.
    San-Blas G; Calcagno AM; San-Blas F
    J Med Vet Mycol; 1993; 31(2):169-74. PubMed ID: 8389848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.
    Cruz RC; Werneck SM; Oliveira CS; Santos PC; Soares BM; Santos DA; Cisalpino PS
    J Clin Microbiol; 2013 Feb; 51(2):436-43. PubMed ID: 23175254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
    Hahn RC; Hamdan JS
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1997-2000. PubMed ID: 10858371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
    Barros ME; Hamdan JS
    Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity of trichothecenes from Fusarium sp. against clinical isolates of Paracoccidioides brasiliensis.
    Campos FF; Johann S; Cota BB; Alves TM; Rosa LH; Caligiorne RB; Cisalpino PS; Rosa CA; Zani CL
    Mycoses; 2011 Jul; 54(4):e122-9. PubMed ID: 20337937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.
    Sar B; Boy S; Keo C; Ngeth CC; Prak N; Vann M; Monchy D; Sarthou JL
    J Clin Microbiol; 2006 Nov; 44(11):4208-10. PubMed ID: 16971649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
    Cuenca-Estrella M; Rodriguez D; Almirante B; Morgan J; Planes AM; Almela M; Mensa J; Sanchez F; Ayats J; Gimenez M; Salvado M; Warnock DW; Pahissa A; Rodriguez-Tudela JL;
    J Antimicrob Chemother; 2005 Feb; 55(2):194-9. PubMed ID: 15618284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
    van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin protects Paracoccidioides brasiliensis from the effects of antimicrobial photodynamic inhibition and antifungal drugs.
    Baltazar LM; Werneck SM; Soares BM; Ferreira MV; Souza DG; Pinotti M; Santos DA; Cisalpino PS
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4003-11. PubMed ID: 25896704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility.
    da Silva MB; Marques AF; Nosanchuk JD; Casadevall A; Travassos LR; Taborda CP
    Microbes Infect; 2006 Jan; 8(1):197-205. PubMed ID: 16213179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D; Díaz MC; Silva V
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.
    Brandt ME; Pfaller MA; Hajjeh RA; Hamill RJ; Pappas PG; Reingold AL; Rimland D; Warnock DW;
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3065-9. PubMed ID: 11600357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.